This inventor holds 5 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: The Rockefeller University. Active years: 2015-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2021
Title: Innovations of Jonathan Schmitz in Bacteriophage Research
Introduction
Jonathan Schmitz is a notable inventor based in New York, NY (US), recognized for his contributions to the field of bacteriophage research. He holds a total of five patents, focusing on innovative methods for the detection and treatment of gram-positive bacteria. His work has significant implications for medical treatments and public health.
Latest Patents
Among his latest patents, Schmitz has developed bacteriophage lysins for the detection and treatment of gram-positive bacteria. The present invention provides methods, compositions, and articles of manufacture useful for the prophylactic and therapeutic amelioration and treatment of gram-positive bacteria and related conditions. This invention incorporates and utilizes derived bacteriophage lysins, particularly PlySs2 and/or PlySs1 lytic enzymes and variants thereof, including truncations. Methods for treatment of humans are also provided, showcasing the potential of his research in clinical applications.
Career Highlights
Jonathan Schmitz is affiliated with The Rockefeller University, where he conducts his research and development. His work is characterized by a strong focus on innovative solutions to combat bacterial infections, particularly those caused by gram-positive bacteria. His contributions to the field have been recognized through multiple patents, reflecting his commitment to advancing medical science.
Collaborations
Some of his notable coworkers include Vincent A. Fischetti and Daniel Gilmer, who collaborate with him on various research projects. Their combined expertise enhances the impact of their work in bacteriophage research.
Conclusion
Jonathan Schmitz's innovative work in bacteriophage research and his patents on lysins for bacterial treatment highlight his significant contributions to medical science. His research continues to pave the way for new therapeutic approaches in combating bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile